0001615774-15-001407.txt : 20150608
0001615774-15-001407.hdr.sgml : 20150608
20150608171922
ACCESSION NUMBER: 0001615774-15-001407
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150604
FILED AS OF DATE: 20150608
DATE AS OF CHANGE: 20150608
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SECOND SIGHT MEDICAL PRODUCTS INC
CENTRAL INDEX KEY: 0001266806
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 000000000
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
BUSINESS PHONE: 818-833-5000
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ripley Anne-Marie Juliette
CENTRAL INDEX KEY: 0001625186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36747
FILM NUMBER: 15919166
MAIL ADDRESS:
STREET 1: 12744 SAN FERNANDO ROAD, BLDG. 3
CITY: SYLMAR
STATE: CA
ZIP: 91342
4
1
s101281_form4.xml
4
X0306
4
2015-06-04
0
0001266806
SECOND SIGHT MEDICAL PRODUCTS INC
EYES
0001625186
Ripley Anne-Marie Juliette
12744 SAN FERNANDO ROAD, BLDG. 3
SYLMAR
CA
91342
0
1
0
0
VP Regulatory Affairs
COMMON STOCK
2015-06-04
4
M
0
4371
4.75
A
4371
D
COMMON STOCK
2015-06-04
4
S
0
4371
15.00
D
0
D
Option
4.75
2015-06-04
4
M
0
4371
0
D
2015-09-01
Common Stock
4371
0
D
Option
4.75
2016-01-01
Common Stock
2500
2500
D
Option
5.00
2017-01-01
Common Stock
6125
6125
D
Option
5.00
2018-04-01
Common Stock
4750
4750
D
Option
5.00
2018-11-01
Common Stock
25000
25000
D
Option
5.00
2019-02-01
Common Stock
6750
6750
D
Option
5.00
2020-02-01
Common Stock
10125
10125
D
Option
5.00
2020-02-01
Common Stock
10625
10625
D
Option
5.00
2021-03-01
Common Stock
8313
8313
D
Option
5.00
2022-03-01
Common Stock
5813
5813
D
Option
5.00
2024-04-01
Common Stock
3125
3125
D
Ms. Ripley exercised 4,371 vested options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014.
These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's prospectus dated November 20, 2014.
These are vested employee options currently exercisable.
Excludes employee options, covering 89,781 shares, not exercisable for over 60 days from this date. Sales reported in this Form 4 constitute the final trades contemplated upon expiration of the six month lock-up noted in footnote 2 above, with the Reporting Person's share sales after this date remaining subject to a 12 month lock-up that commenced from the IPO date.
/s/ Anne-Marie Ripley
2015-06-08